Richard Sanderson of IPS discusses risk management, predictive controls, and innovation to address skilled labor shortages in pharma construction.
Richard Sanderson
Advertisement
Rich Sanderson is Regional Operations Director for IPS in Pennsylvania. Rich brings extensive EPCM experience and almost three decades in construction management in the UK and US, including 25 years in US life sciences. For the past 8 years with IPS he has served as an Operations Director leading large, complex EPCM projects and teams for major clients including Merck and GSK. He is recognized for his ability to elevate team performance through Lean practices, collaboration and align stakeholders to deliver outcomes.
Articles by Richard Sanderson
Richard Sanderson, IPS, discusses pharma capital project cost pressures, bloated deliverable lists, and making the case for EPCM's end-to-end delivery model.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
3
USP Reports Drug Discontinuations on the Rise
4
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
5